PubMed for id: 1806

Year	Number of Results
1988	1
1989	1
1990	1
1991	1
1992	2
1993	1
1994	2
1996	1
1997	5
1998	1
1999	2
2000	2
2001	3
2002	10
2003	5
2004	9
2005	10
2006	11
2007	19
2008	11
2009	18
2010	23
2011	15
2012	12
2013	14
2014	15
2015	16
2016	20
2017	13
2018	9
2019	5
2020	6
2021	8
2022	10
2023	10
2024	3

1

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.

Larrue R, Fellah S, Hennart B, Sabaouni N, Boukrout N, Van der Hauwaert C, Delage C, Cheok M, Perrais M, Cauffiez C, Allorge D, Pottier N. Larrue R, et al. Pharmacogenomics J. 2024 Jan 12;24(1):1. doi: 10.1038/s41397-023-00322-x. Pharmacogenomics J. 2024. PMID: 38216550 Free PMC article.

2

Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort.

Medwid SJ, Mailloux JL, Wigle TJ, Kim RB. Medwid SJ, et al. Pharmacogenet Genomics. 2024 Apr 1;34(3):83-87. doi: 10.1097/FPC.0000000000000521. Epub 2024 Jan 15. Pharmacogenet Genomics. 2024. PMID: 38215018

3

Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping.

Royer B, Launay M, Ciccolini J, Derain L, Parant F, Thomas F, Guitton J. Royer B, et al. ESMO Open. 2023 Jun;8(3):101577. doi: 10.1016/j.esmoop.2023.101577. Epub 2023 May 31. ESMO Open. 2023. PMID: 37267808 Free PMC article.

4

Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study.

Miarons M, Manzaneque Gordón A, Riera P, Gutiérrez Nicolás F; RedDPYD Research Group with the Spanish Society of Hospital Pharmacy (SEFH). Miarons M, et al. Oncologist. 2023 May 8;28(5):e304-e308. doi: 10.1093/oncolo/oyad077. Oncologist. 2023. PMID: 37014829 Free PMC article.

5

Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapy.

Doornhof KR, van der Linden PD, Boeke GM, Willemsen AECAB, Daskapan A. Doornhof KR, et al. Eur J Clin Pharmacol. 2023 Apr;79(4):493-501. doi: 10.1007/s00228-023-03466-8. Epub 2023 Feb 9. Eur J Clin Pharmacol. 2023. PMID: 36757428

6

DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation.

Wigle TJ, Medwid S, Ross C, Schwarz UI, Kim RB. Wigle TJ, et al. Curr Oncol. 2023 Jan 4;30(1):663-672. doi: 10.3390/curroncol30010051. Curr Oncol. 2023. PMID: 36661700 Free PMC article. Review.

7

Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population.

Kanai M, Kawaguchi T, Kotaka M, Manaka D, Hasegawa J, Takagane A, Munemoto Y, Kato T, Eto T, Touyama T, Matsui T, Shinozaki K, Matsumoto S, Mizushima T, Mori M, Sakamoto J, Ohtsu A, Yoshino T, Saji S, Matsuda F. Kanai M, et al. Cancer Med. 2023 Apr;12(7):7808-7814. doi: 10.1002/cam4.5541. Epub 2022 Dec 16. Cancer Med. 2023. PMID: 36524458 Free PMC article.

8

Fluoropyrimidine-associated toxicity and DPYD variants c.85T>C, c.496A>G, and c.1236G>A: impact of haplotype.

Medwid S, Wigle TJ, Kim RB. Medwid S, et al. Cancer Chemother Pharmacol. 2023 Jan;91(1):97-102. doi: 10.1007/s00280-022-04491-7. Epub 2022 Nov 10. Cancer Chemother Pharmacol. 2023. PMID: 36357798

9

Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations.

Paulsen NH, Qvortrup C, Vojdeman FJ, Plomgaard P, Andersen SE, Ramlov A, Bertelsen B, Rossing M, Nielsen CG, Hoffmann-Lücke E, Greibe E, Spangsberg Holm H, Nielsen HH, Lolas IBY, Madsen JS, Bergmann ML, Mørk M, Fruekilde PBN, Bøttger P, Petersen PC, Nissen PH, Feddersen S, Bergmann TK, Pfeiffer P, Damkier P. Paulsen NH, et al. Acta Oncol. 2022 Nov;61(11):1400-1405. doi: 10.1080/0284186X.2022.2132117. Epub 2022 Oct 18. Acta Oncol. 2022. PMID: 36256873 No abstract available.

10

Pharmacogenetic Study of the Dihydropyridine Dehydrogenase Gene in Jordanian Patients with Colorectal Cancer.

Almashagbah NA, Mahasneh AA, Bodoor KG. Almashagbah NA, et al. Asian Pac J Cancer Prev. 2022 Sep 1;23(9):3061-3069. doi: 10.31557/APJCP.2022.23.9.3061. Asian Pac J Cancer Prev. 2022. PMID: 36172669 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

263 results

Results by year